Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/190002
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Rey Reñones, Cristina | - |
dc.contributor.author | Martinez Torres, Sara | - |
dc.contributor.author | Martín Luján, Francisco M | - |
dc.contributor.author | Pericas, Carles | - |
dc.contributor.author | Redondo, Ana | - |
dc.contributor.author | Vilaplana Carnerero, Carles | - |
dc.contributor.author | Domínguez García, Àngela | - |
dc.contributor.author | Grau, Maria | - |
dc.date.accessioned | 2022-10-19T14:32:53Z | - |
dc.date.available | 2022-10-19T14:32:53Z | - |
dc.date.issued | 2022-08-26 | - |
dc.identifier.issn | 2227-9059 | - |
dc.identifier.uri | http://hdl.handle.net/2445/190002 | - |
dc.description.abstract | Type-2 diabetes mellitus (T2DM) is a chronic metabolic disorder. The incidence and prevalence of patients with T2DM are increasing worldwide, even reaching epidemic values in most high- and middle-income countries. T2DM could be a risk factor of developing complications in other diseases. Indeed, some studies suggest a bidirectional interaction between T2DM and COVID-19. A growing body of evidence shows that COVID-19 prognosis in individuals with T2DM is worse compared with those without. Moreover, various studies have reported the emergence of newly diagnosed patients with T2DM after SARS-CoV-2 infection. The most common treatments for T2DM may influence SARS-CoV-2 and their implication in infection is briefly discussed in this review. A better understanding of the link between TD2M and COVID-19 could proactively identify risk factors and, as a result, develop strategies to improve the prognosis for these patients. | - |
dc.format.extent | 12 p. | - |
dc.format.mimetype | application/pdf | - |
dc.language.iso | eng | - |
dc.publisher | MDPI | - |
dc.relation.isformatof | Reproducció del document publicat a: | - |
dc.relation.ispartof | Biomedicines, 2022, vol. 10, p. 2089 | - |
dc.rights | cc-by (c) Rey Reñones, Cristina et al., 2022 | - |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | - |
dc.source | Articles publicats en revistes (Medicina) | - |
dc.subject.classification | Diabetis | - |
dc.subject.classification | COVID-19 | - |
dc.subject.classification | Epidemiologia | - |
dc.subject.other | Diabetes | - |
dc.subject.other | COVID-19 | - |
dc.subject.other | Epidemiology | - |
dc.title | Type 2 diabetes mellitus and COVID-19: a narrative review | - |
dc.type | info:eu-repo/semantics/article | - |
dc.type | info:eu-repo/semantics/publishedVersion | - |
dc.identifier.idgrec | 724610 | - |
dc.date.updated | 2022-10-19T14:32:53Z | - |
dc.rights.accessRights | info:eu-repo/semantics/openAccess | - |
dc.identifier.pmid | 36140191 | - |
Appears in Collections: | Articles publicats en revistes (Medicina) Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL)) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
724610.pdf | 875.04 kB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License